Researchers at the Cleveland Clinic in the US said genetic testing to assess risk factors for patients with a family history of melanoma is rare, with limited previous studies showing that only 2-2.5 percent of all cases are genetic. . ,The results, published in the Journal of the American...
LONDON (AP) — An international clinical trial testing a new cancer immunotherapy that prevents skin cancer from recurring has recruited its first patient in Britain this week.The mRNA-based technology, the same vaccine technology used for some COVID vaccinations, is being targeted at people...